CRL
CRL
NYSE · Life Sciences Tools & Services

Charles River Laboratories

$337.52
+24.50 (+7.83%)
As of Nov 7, 1:17 AM ET ·
Day Range $316.61 — $339.97
52W Range $146.20 — $379.63

Performance

1D +0.00%
1W -0.30%
1M +13.26%
3M +21.85%
6M +100.36%
1Y +100.84%
YTD +66.74%
Open$318.73
Previous Close$313.02
Day High$339.97
Day Low$316.61
52W High$379.63
52W Low$146.20
Volume—
Avg Volume1.35M
Market Cap15.64B
P/E Ratio—
EPS$-4.85
SectorLife Sciences Tools & Services

Technical Indicators

Full analysis →
SMA 50 $305.60 Above
SMA 200 $224.56 Above
RSI (14) 59.3 Neutral
Trend Golden Cross Bullish

Analyst Ratings

Strong Buy
23 analysts
18 Buy 5 Hold 0 Sell
Price Target -78.9% upside
Current
$337.52
Target
$71.21
$57.45 $71.21 avg $105.86

Key Financials

FY 2026 FY 2025 FY 2024
Revenue 3.75B 3.74B 1.98B
Net Income -134,934,956 -121,042,021 304.29M
Profit Margin -3.6% -3.4% 15.4%
EBITDA 190.92M 180.78M 664.62M
Free Cash Flow — — 311.82M
Rev Growth +0.3% +0.3% +16.2%
Debt/Equity 0.68 0.68 0.57

Life Sciences Tools & Services Peers

Symbol Name Price Change P/E Mkt Cap
TMO Thermo Fisher Scientific Inc $694.76 +2.63% 36.1 255.13B
DHR Danaher Corp $230.25 +1.73% 36.9 159.65B
A Agilent Technologies Inc $174.76 +1.73% 33.6 48.43B
IQV Iqvia Holdings Inc $271.83 +2.62% 32.2 44.90B
MTD Mettler-Toledo International $1,722.15 +2.57% 38.5 34.87B
WAT Waters Corp $457.60 +1.00% 260.1 43.22B